[go: up one dir, main page]

DE69534575D1 - Trägerstoff zur verzögerten Freisetzung - Google Patents

Trägerstoff zur verzögerten Freisetzung

Info

Publication number
DE69534575D1
DE69534575D1 DE69534575T DE69534575T DE69534575D1 DE 69534575 D1 DE69534575 D1 DE 69534575D1 DE 69534575 T DE69534575 T DE 69534575T DE 69534575 T DE69534575 T DE 69534575T DE 69534575 D1 DE69534575 D1 DE 69534575D1
Authority
DE
Germany
Prior art keywords
sustained release
release carrier
cross
heteropolysaccharide
linking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69534575T
Other languages
English (en)
Other versions
DE69534575T2 (de
Inventor
Anand R Baichwal
Troy W Mccall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Penwest Pharmaceuticals Co
Original Assignee
Penwest Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Penwest Pharmaceuticals Co filed Critical Penwest Pharmaceuticals Co
Application granted granted Critical
Publication of DE69534575D1 publication Critical patent/DE69534575D1/de
Publication of DE69534575T2 publication Critical patent/DE69534575T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Character Spaces And Line Spaces In Printers (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Superstructure Of Vehicle (AREA)
  • Memory System Of A Hierarchy Structure (AREA)
  • Push-Button Switches (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69534575T 1994-04-25 1995-03-21 Trägerstoff zur verzögerten Freisetzung Expired - Fee Related DE69534575T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23262594A 1994-04-25 1994-04-25
US232625 1994-04-25

Publications (2)

Publication Number Publication Date
DE69534575D1 true DE69534575D1 (de) 2005-12-08
DE69534575T2 DE69534575T2 (de) 2006-07-13

Family

ID=22873888

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69524358T Expired - Lifetime DE69524358T2 (de) 1994-04-25 1995-03-21 Trägerstoff zur verzögerten freisetzung
DE69534575T Expired - Fee Related DE69534575T2 (de) 1994-04-25 1995-03-21 Trägerstoff zur verzögerten Freisetzung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69524358T Expired - Lifetime DE69524358T2 (de) 1994-04-25 1995-03-21 Trägerstoff zur verzögerten freisetzung

Country Status (18)

Country Link
EP (2) EP1145712B1 (de)
JP (1) JP3279318B2 (de)
KR (1) KR100232020B1 (de)
CN (1) CN1131023C (de)
AT (2) ATE308318T1 (de)
AU (1) AU705378B2 (de)
CA (1) CA2164513C (de)
DE (2) DE69524358T2 (de)
DK (1) DK0706377T3 (de)
ES (2) ES2246961T3 (de)
FI (1) FI119353B (de)
HK (1) HK1040487B (de)
HU (1) HU219818B (de)
IL (1) IL113167A (de)
MX (1) MX9600022A (de)
PT (1) PT706377E (de)
TW (1) TW357085B (de)
WO (1) WO1995028916A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890524B1 (en) 1997-04-04 2005-05-10 Monsanto Company Hydrolyzable delivery system using cross-linked polymeric resins as vehicles
WO1998044951A2 (en) * 1997-04-04 1998-10-15 Monsanto Company Hydrolysable delivery system using cross-linked polymeric resins as vehicles
AU6783498A (en) 1997-04-04 1998-10-30 Monsanto Company Ph-selective delivery system using cross-linked polymeric resins as vehicles
AU2002316582B2 (en) 2001-07-06 2007-03-15 Endo Pharmaceuticals, Inc. Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
CA2459976A1 (en) * 2001-09-26 2003-04-03 Penwest Pharmaceuticals Company Opioid formulations having reduced potential for abuse
CA2481091A1 (en) * 2002-04-05 2003-10-23 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
KR101999055B1 (ko) * 2018-02-28 2019-10-01 경북대학교 산학협력단 과황산 이온 서방성 구조체, 이의 제조방법 및 이를 이용한 유기 오염 물질 처리 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303691A (en) * 1977-11-09 1981-12-01 Anderson, Clayton & Co. Proteinaceous food product
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4764380A (en) * 1982-03-22 1988-08-16 Alza Corporation Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
HU209251B (en) * 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol
US5399362A (en) * 1994-04-25 1995-03-21 Edward Mendell Co., Inc. Once-a-day metoprolol oral dosage form

Also Published As

Publication number Publication date
ES2246961T3 (es) 2006-03-01
HUT73636A (en) 1996-08-28
DE69524358T2 (de) 2002-06-13
MX9600022A (es) 1998-06-30
FI956209L (fi) 1995-12-22
EP0706377B1 (de) 2001-12-05
EP0706377A4 (de) 1996-11-06
HU219818B (hu) 2001-08-28
CN1127469A (zh) 1996-07-24
DK0706377T3 (da) 2002-04-02
DE69534575T2 (de) 2006-07-13
ATE308318T1 (de) 2005-11-15
JP3279318B2 (ja) 2002-04-30
CA2164513A1 (en) 1995-11-02
HK1040487B (zh) 2006-05-12
PT706377E (pt) 2002-05-31
EP1145712A1 (de) 2001-10-17
HU9503456D0 (en) 1996-02-28
ES2164764T3 (es) 2002-03-01
KR100232020B1 (ko) 1999-12-01
FI956209A0 (fi) 1995-12-22
WO1995028916A1 (en) 1995-11-02
IL113167A0 (en) 1995-06-29
CN1131023C (zh) 2003-12-17
EP1145712B1 (de) 2005-11-02
TW357085B (en) 1999-05-01
EP0706377A1 (de) 1996-04-17
ATE209906T1 (de) 2001-12-15
JPH08512061A (ja) 1996-12-17
CA2164513C (en) 1999-09-21
AU2198295A (en) 1995-11-16
FI119353B (fi) 2008-10-31
AU705378B2 (en) 1999-05-20
HK1040487A1 (en) 2002-06-14
DE69524358D1 (de) 2002-01-17
KR960703016A (ko) 1996-06-19
IL113167A (en) 2001-01-28

Similar Documents

Publication Publication Date Title
FI961996A0 (fi) Pitkitetysti vapauttavat valmisteet metoprololin 24 tunnin pituiseksi vapauttamiseksi
IL112637A0 (en) A pharmaceutical composition containing oxybutynin and methods for the preparation thereof
ATE187167T1 (de) Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
BR9609537A (pt) Composições farmacêuticas
DE69523438D1 (de) Orale metoprolol-dosisform des typs "einmal täglich"
SG28285A1 (en) Method for molding dental restorations and related apparatus
GB9227182D0 (en) Composition for dental restorative material
DK0480238T3 (da) Hydrofile aftryksmasser
FR2627984B1 (fr) Composition pulverulente a base d'alginate pour empreintes dentaires
GB9514888D0 (en) Silicone composition for dental impressions
EP0461586A3 (en) Dental composition for impression-taking
DE69534575D1 (de) Trägerstoff zur verzögerten Freisetzung
IT9021263A0 (it) Composizioni farmaceutiche orali a base di melatonina
BR9814127A (pt) Nova forma de dosagem oral para carvedilol
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
HK1004549A1 (en) Carbostyril derivatives and pharmaceutical compositions containing the same for use as a disturbance-of-consciousness improving agent central nervous system stimulant or sigma receptor agonist
ZA916570B (en) Desensitizing dental composition
FR2687068B1 (fr) Composition pour empreintes dentaires.
ITMI940515V0 (it) Dispositivo simmetropredeterminatore per la riproduzione del tracciato dell'arcata dentale
IT1235158B (it) Composizione farmaceutica a base di derivati carbazolici e metanolici nonche' impiego e confezione per essa

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee